MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.

MLA

Tong, L., et al. “MicroRNA-365 Inhibits the Progression of Lung Adenocarcinoma through Targeting ETS1 and Inactivating AKT/MTOR Pathway.” European Review for Medical & Pharmacological Sciences, vol. 24, no. 9, May 2020, pp. 4836–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=143215319&authtype=sso&custid=ns315887.

APA

Tong, L., Han, W.-Z., Wang, J.-L., Sun, N.-N., & Zhuang, M. (2020). MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway. European Review for Medical & Pharmacological Sciences, 24(9), 4836–4845.

Chicago

Tong, L., W.-Z. Han, J.-L. Wang, N.-N. Sun, and M. Zhuang. 2020. “MicroRNA-365 Inhibits the Progression of Lung Adenocarcinoma through Targeting ETS1 and Inactivating AKT/MTOR Pathway.” European Review for Medical & Pharmacological Sciences 24 (9): 4836–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=143215319&authtype=sso&custid=ns315887.